Systemic distribution, subcellular localization and differential expression of sphingosine-1-phosphate receptors in benign and malignant human tissues

Experimental and Molecular Pathology

Volumn 97, Issue 2, 2014, Pages 259-265

  Wang, Chunyi ^a,b   Mao, Jinghe ^c   Redfield, Samantha ^b   Mo, Yinyuan ^d   Lage, Janice M ^b   Zhou, Xinchun ^b,d  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c TOUGALOO COLLEGE   (United States)

^d UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Adrenal gland; Cancer; Colon; Immunohistochemistry (IHC); Liver; Lung; Neural system; Ovary; Sphingosine 1 phosphate (S1P) receptors (S1PRs); Stomach

Indexed keywords

G PROTEIN COUPLED RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 1; SPHINGOSINE 1 PHOSPHATE RECEPTOR 2; SPHINGOSINE 1 PHOSPHATE RECEPTOR 3; SPHINGOSINE 1 PHOSPHATE RECEPTOR 4; SPHINGOSINE 1 PHOSPHATE RECEPTOR 5; UNCLASSIFIED DRUG;

ADRENAL GLAND; ARTICLE; BRAIN; CANCER CELL LINE; CANCER GROWTH; CELL MEMBRANE; CELL NUCLEUS; CELLULAR DISTRIBUTION; COLON; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LIVER; LUNG; LYMPHOID TISSUE; OVARY; PANCREAS; PROTEIN EXPRESSION; SKIN; SOFT TISSUE; STOMACH; STUDENT T TEST; TISSUE MICROARRAY; UTERINE CERVIX; UTERUS;

ADRENAL GLAND; CANCER; COLON; IMMUNOHISTOCHEMISTRY (IHC); LIVER; LUNG; NEURAL SYSTEM; OVARY; SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTORS (S1PRS); STOMACH;

GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; NEOPLASMS; ORGAN SPECIFICITY; PROTEIN TRANSPORT; RECEPTORS, LYSOSPHINGOLIPID;

EID: 84905858913     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.07.013     Document Type: Article

References (40)

1. Beckham T.H., Cheng J.C., Lu P., Shao Y., Troyer D., Lance R., Marrison S.T., Norris J.S., Liu X. Acid ceramidase induces sphingosine kinase 1/S1P receptor 2-mediated activation of oncogenic Akt signaling. Oncogenesis 2013, 2:e49.
2. Chae S., Proia R., Hla T. Constitutive expression of the S1P1 receptor in adult tissues. Prostaglandins Other Lipid Mediat. 2004, 73(1-2):141-150.
3. Fisher K., Pop A., Koh W., Anthis N., Saunders W., Davis G. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling. Mol. Cancer 2006, 5:69.
4. Garris C.S., Blaho V.A., Hla T., Han M.H. Sphingosine-1-phosphate receptor 1 (S1P1) signaling in T cells: trafficking and beyond. Immunology 2014, 43(1):15-24. (Genomics). 10.1111/imm.12272.
5. Goetzl E., Graeler M., Huang M., Shankar G. Lysophospholipid growth factors and their G protein-coupled receptors in immunity, coronary artery disease, and cancer. Sci. World J. 2002, 2:324-338.
6. Gräler M., Bernhardt G., Lipp M. EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue. Genomics 1998, 53(2):164-169.
7. Hiraga Y., Kihara A., Sano T., Igarashi Y. Changes in S1P1 and S1P2 expression during embryonal development and primitive endoderm differentiation of F9 cells. Biochem. Biophys. Res. Commun. 2006, 344(3):852-858.
8. Hla T., Maciag T. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J. Biol. Chem. 1990, 265(16):9308-9313.
9. Hu W., Li L., Jing B., Zhao Y., Wang C., Feng L., Xie Y. Effect of S1P5 on proliferation and migration of human esophageal cancer cells. World J. Gastroenterol. 2010, 16(15):1859-1866.
10. Huang Y., Chang C., Tang C., Lin Y., Ju T., Huang W., Lee H. Extrinsic sphingosine 1-phosphate activates S1P5 and induces autophagy through generating endoplasmic reticulum stress in human prostate cancer PC-3 cells. Cell. Signal. 2014, 26(3):611-618.
11. Im D., Heise C., Ancellin N., O'Dowd B., Shei G., Heavens R., Rigby M., Hla T., Mandala S., McAllister G., George S., Lynch K. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. J. Biol. Chem. 2000, 275(19):14281-14286.
12. Im D., Clemens J., Macdonald T., Lynch K. Characterization of the human and mouse sphingosine 1-phosphate receptor, S1P5 (Edg-8): structure-activity relationship of sphingosine1-phosphate receptors. Biochemistry 2001, 40(46):14053-14060.
13. Kawahara S., Otsuji Y., Nakamura M., Murakami M., Murate T., Matsunaga T., Kanoh H., Seishima M., Banno Y., Hara A. Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells. Anticancer Drugs 2013, 24(5):473-483.
14. Kondo S., Bottos A., Allegood J.C., Masson R., Maurer F.G., Genoud C., Kaeser P., Huwiler A., Murakami M., Spiegel S., Hynes N. Memo has a novel role in S1P signaling and crucial for vascular development. PLoS One 2014, 9(4):e94114.
15. Kunkel G.T., Maceyka M., Milstien S., Spiegel S. Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat. Rev. Drug Discov. 2013, 12(9):688-702.
16. Liang J., Nagahashi M., Kim E.Y., Harikumar K.B., Yamada A., Huang W.C., Hait N.C., Allegood J.C., Price M.M., Avni D., Takabe K., Kordula T., Milstien S., Spiegel S. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell 2013, 23(1):107-120.
17. Licht T., Tsirulnikov L., Reuveni H., Yarnitzky T., Ben-Sasson S.A. Induction of pro-angiogenic signaling by a synthetic peptide derived from the second intracellular loop of S1P3 (EDG3). Blood 2003, 102:2099-2107.
18. Liu C., Hla T. The Mouse Gene for the Inducible G-Protein-Coupled Receptor Edg-1 1997.
19. Maceyka M., Harikumar K.B., Milstien S., Spiegel S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 2012, 22(1):50-60.
20. 2 receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN. Biochem. Biophys. Res. Commun. 2008, 366(4):963-968.
21. Okhotsk J., Long J.S., Orange C., Elsberry B., Mallon E., Doughty J., Pyne S., Pyne N.J., Edwards J. Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in estrogen receptor-negative breast cancer. Br. J. Cancer 2012, 106(8):1453-1459.
22. Okhotsk J., Edwards J., Elsberry B., Watson C., Orange C., Mallon E., Pyne S., Pyne N.J. Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1-phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor-positive breast cancer. Int. J. Cancer 2013, 132(3):605-616.
23. Olivera A., Spiegel S. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 1993, 365(6446):557-560.
24. Pyne N.J., Pyne S. Sphingosine-1-phosphate and cancer. Nat. Rev. Cancer 2010, 10:489-503.
25. Pyne S., Pyne N.J. New perspectives on the role of sphingosine 1-phosphate in cancer. Handb. Exp. Pharmacol. 2013, (216):55-71.
26. Qu Z., Cheuk B., Cheng S. Differential expression of sphingosine-1-phosphate receptors in abdominal aortic aneurysms. Mediat. Inflamm. 2012, 2012:643609.
27. Schmouder R., Hariry S., David O.J. Placebo-controlled study of the effects of fingolimod on cardiac rate and rhythm and pulmonary function in healthy volunteers. Eur. J. Clin. Pharmacol. 2012, 68(4):355-362.
28. Sekine Y., Suzuki K., Remaley A. HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion. Prostate 2011, 71(7):690-699.
29. Soliven B., Miron V., Chun J. The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators. Neurology 2011, 76(8 Suppl 3):S9-S14.
30. Spiegel S. Sphingosine 1-phosphate: a prototype of a new class of second messengers. J. Leukoc. Biol. 1999, 65:341-344.
31. Spiegel S., Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 2003, 4:397-407.
32. Sukocheva O., Wadham C., Xia P. Estrogen defines the dynamics and destination of transactivated EGF receptor in breast cancer cells: role of S1P[U+2083] receptor and Cdc42. Exp. Cell Res. 2013, 319(4):455-465.
33. Takuwa Y., Okamoto Y., Yoshioka K., Takuwa N. Sphingosine-1-phosphate signaling in physiology and diseases. Biofactors 2012, 38(5):329-337.
34. i-coupled receptors: role of ERK MAP kinase and phosphatidylinositol 3-kinase beta. Cancer Lett. 2002, 181(2):195-204.
35. 12 families of heterotrimeric G proteins. J. Biol. Chem. 1999, 274(39):27351-27358.
36. Yamashita H., Kitayama J., Shida D., Yamaguchi H., Mori K., Osada M., Aoki S., Yatomi Y., Takuwa Y., Nagawa H. Sphingosine 1-phosphate receptor expression profile in human gastric cancer cells: differential regulation on the migration and proliferation. J. Surg. Res. 2006, 130(1):80-87.
37. Zhang H., Desai N.N., Olivera A., Seki T., Brooker G., Spiegel S. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J. Cell Biol. 1991, 114(1):155-167.
38. Zhang G., Contos J., Weiner J., Fukushima N., Chun J. Comparative analysis of three murine G-protein coupled receptors activated by sphingosine-1-phosphate. Gene 1999, 227(1):89-99.
39. Zhang W., Zhao J., Lee J.F., Grating A., Jawed H., Lambic W.L., Honan K.V., Lee M.J. TS-1-mediated transcriptional up-regulation of CD44 is required for sphingosine-1-phosphate receptor subtype 3-stimulated chemo taxis. J. Biol. Chem. 2013, 288(45):32126-32137.
40. Zhou X., Lawrence T.J., He Z., Pound C., Mao J., Bigler S. The expression level of lysophosphatidylcholine acyltransferase 1 (LPCAT1) correlates to the progression of prostate cancer. Exp. Mol. Pathol. 2012, 92(1):105-110.